The present investigation evaluated the measurement model and construct validity of marijuana use motives as measured by the Marijuana Motives Measure (MMM; Simons, Correia, Carey, & Borsari, 1998). Confirmatory factor analysis (CFA) and incremental tests of validity of marijuana use motives were conducted on a sample of young adult marijuana users (n = 227, 127 women; M age = 20.11, SD = 4.30 years). As hypothesized, CFA analysis of marijuana use motives, as indexed by the MMM, demonstrated support for a multidimensional measurement model; specifically, a five-factor solution denoting Enhancement, Conformity, Expansion, Coping, and Social motives for marijuana use, each with satisfactory levels of internal consistency. Subsequent tests of incremental validity suggested that only certain motives were uniquely related to current substance use and cognitive-affective factors. Results are discussed in relation to refining the scientific understanding of marijuana use motives.
Given the limited work on the MMM, there is a need to independently replicate the factor structure of the measure using confirmatory factory analysis (CFA).
There also is limited work on the relations between marijuana use motives and current marijuana use as well as other forms of substance use. For example, it is presently unclear whether specific marijuana use motives uniquely contribute to the prediction of marijuana use and other forms of commonly used substances (tobacco and alcohol). As another example, there has been little study of the relation between motives for marijuana use and cognitiveaffective factors. It is therefore important to test the incremental (or relative) validity of motives: to what extent do motives predict clinically relevant phenomena above and beyond substance use, gender, and related variables? Such tests would explicate the incremental validity of marijuana use motives in terms of substance use and cognitive-affective vulnerability after accounting for the variance attributable to substance use factors common to marijuana users.
With this background, the present study addressed the limitations of past work using the MMM by (1) applying CFA analysis to test the latent structure and measurement model of marijuana use motives; and (2) testing the incremental validity of marijuana use motives in terms of (a) substance use and (b) cognitive-affective factors.
Method

1 Participants and Procedure
The sample consisted of 227 community and university recruited young adult marijuana smokers (127 women) with a mean age of 20.11 (SD = 4.30) years. For inclusion in the study, participants had to endorse current marijuana use (use in past 30 days). Upon arrival to the laboratory, participants provided verbal and written consent, and subsequently completed a battery of self-report questionnaires and were compensated $25 for their efforts. Participants were excluded if they showed limited mental competency (failure to be oriented to person, place, and time) or were not able to give informed, written consent; no participants were excluded based upon these two criteria. The study was approved by the Institutional Review Board at the University of Vermont.
Measures
Participants completed a battery of self-report assessments including (1) Marijuana Motives Measure (MMM; Simons et al., 1998) ; (2) Marijuana Smoking History Questionnaire (MSHQ; Bonn-Miller & Zvolensky, 2005) to assess age of marijuana smoking onset and past 30-day use; (3) Smoking History Questionnaire (SHQ; Brown, Lejuez, Kahler, & Strong, 2002) to assess daily smoking; (4) Alcohol Assessment to assess the product of the weekly frequency of use by quantity of alcoholic beverages consumed (Wechsler, Davenport, Dowdall, Moeykens, & Castillo, 1994) ; (5) Positive Affect Negative Affect Scale (Watson, Clark, & Tellegen, 1988) to assess negative affectivity; (6) Anxiety Sensitivity Index (ASI; Reiss, Peterson, Gursky, & McNally, 1986) to assess anxiety sensitivity; and (7) the Mood and Anxiety Symptom Questionnaire (MASQ; Watson et al., 1995) to assess anxiety and depressive symptoms. (Bollen, 1989) . To assess internal consistency, coefficient alpha was then computed for each of these factors. Observed alpha were as follows: Enhancement (α = .86), Conformity (α = .70) Expansion (α = .91), Coping (α = .88), and Social (α = .84).
Results
1 Confirmatory Factor Analysis and Internal Consistency
2 Incremental Validity for Substance Use and Affect-relevant Factors
Please see Table 2 for a summary of zero-order correlations; Table 3 for a summary of incremental validity findings relevant to substance use; and Table 4 and Table 5 for a comprehensive summary of the incremental validity findings relevant to cognitive-affective factors. In terms of substance use-related outcomes, partially consistent with prediction, Enhancement but not Coping, motives were a significant predictor of past 30-day marijuana use. Conformity motives were a significant negative predictor of marijuana use. In contrast to prediction, Coping motives were a significant predictor of tobacco use; no other motives evidenced significant tobacco-relevant effects. Finally, none of the marijuana use motives incrementally predicted alcohol use volume. In terms of the cognitive-affective outcomes, marijuana use motives significantly predicted positive affectivity, with Enhancement positively and Coping negatively being significant individual predictors. Marijuana use motives also significantly predicted negative affectivity. As hypothesized, Coping motives were the only significant predictor. In terms of anxiety sensitivity, as hypothesized, the Coping factor was the only significant predictor. Marijuana use motives also significantly predicted anxious arousal symptoms and anhedonic depressive symptoms, with Enhancement negatively and Coping positively being significant predictors of both outcomes.
Discussion
CFA analyses of marijuana use motives indexed by the MMM demonstrated support for a multidimensional measurement model. Specifically, there was unambiguous empirical evidence for a five-factor solution denoting Enhancement, Conformity, Expansion, Coping, and Social marijuana use motives (see Table 1 ). The internal consistency of the subscales was good to excellent, ranging from .70 (Conformity motives) to .91 (Expansion motives).
Marijuana use motives collectively explained a large amount of variance in the prediction of marijuana use (30%), after accounting for effects attributable to gender, age at onset of marijuana use, tobacco use and alcohol consumption. However, not all marijuana use motives were incrementally (positively) related to current marijuana use levels. Specifically, Enhancement (9% of unique variance) and Social (3% of unique variance) motives were related to increased use, whereas Conformity motives (5% of unique variance) were negatively related to such use. In contrast to expectation, Coping motives only accounted for a non-significant 2% of unique variance (see Table 3 ). Further analyses indicated marijuana use motives were generally not a significant predictor of tobacco or alcohol use, after accounting for theoretically-relevant variables. The one exception to this pattern of findings was that marijuana use -Coping motives demonstrated a small incremental association (3% of unique variance) with tobacco use.
Coping motives for marijuana use significantly predicted negative affect, anxiety sensitivity, anxious arousal, and anhedonic depressive symptoms. These significant effects, ranging in effect size from 7% to 12% of unique variance, were above and beyond the variance accounted for by the other theoretically-relevant factors of gender, age at onset of marijuana use, past 30-day marijuana use, and tobacco and alcohol use, as well as shared variance with other marijuana use motives. Also, there was a significant negative relation found between Coping motives and positive affectivity. Overall, these data suggest that Coping motives for marijuana use are consistently and relatively robustly related to negative cognitive-affective factors.
Future work can build from the present study by extending the current results to more diverse populations from distinct developmental age ranges (e.g., adolescents, older adults) and clinical service centers. Additionally, it would be useful to extend future work on motives in terms of their relation to marijuana use, abuse, and dependence using structured interview-based diagnostic classification. This line of work may ultimately be instrumental in informing treatment for marijuana abuse and dependence by elucidating the specific motives that may serve to maintain marijuana use as well as the associations between such motives and relevant cognitive-affective factors. 
